Stock A321550 TIUMBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart TiumBio Co., Ltd.

Equities

A321550

KR7321550006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
7,080 KRW -1.80% Intraday chart for TiumBio Co., Ltd. +1.29% -27.53%
May. 08 TiumBio Co., Ltd. Announces Positive Topline Data from Phase 2A Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain CI
Mar. 26 Tiumbio Co., Ltd. Submits CTA for Phase 1B Clinical Trial of TU7710, A Long-Acting Recombinant Activated Factor VII, in Hemophilia A or B Patients CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
TIUMBIO CO., LTD. Stock TiumBio Co., Ltd.
 137M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. A321550 Stock
  4. Charts TiumBio Co., Ltd.
  5. Sector Chart